Edition:
United States

Amedica Corp (AMDA.OQ)

AMDA.OQ on NASDAQ Stock Exchange Capital Market

3.14USD
12:38pm EST
Change (% chg)

$0.21 (+7.17%)
Prev Close
$2.93
Open
$2.94
Day's High
$3.18
Day's Low
$2.94
Volume
3,913
Avg. Vol
11,787
52-wk High
$8.86
52-wk Low
$2.91

Summary

Name Age Since Current Position

B. Sonny Bal

53 2016 Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer

Bryan McEntire

63 2012 Chief Technology Officer

Dana Lyons

2016 Vice President - Sales and Marketing

Eric Stookey

44 2014 Independent Director

David Truetzel

58 Independent Director

Jeffrey White

61 2014 Independent Director

Mike Houston

2014 Director of Investor Relations and Public Relations

Biographies

Name Description

B. Sonny Bal

Dr. B. Sonny Bal, M.D. serves as Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer of the Company. Dr. Bal is Professor of Orthopaedic Surgery at the University of Missouri, Columbia, and Adjunct Professor of Material Sciences at Missouri Science and Technology University at Rolla. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons, the American Association of Hip and Knee Surgeons, and the International Society of Technology in Arthroplasty. Dr. Bal received his M.D. degree from Cornell University and an M.B.A. from Northwestern University, and a J.D. from the University of Missouri. Dr. Bal is a licensed attorney and co-founder of the Bal Brenner law firm in North Carolina. We believe that Dr. Bal’s breadth of experience and scientific expertise in silicon nitride qualifies him to serve as our Chairman, President and Chief Eecutive Officer.

Bryan McEntire

Mr. Bryan J. McEntire is Chief Technology Officer of Company. From June 2004 to May 2012 he served as our Vice President of Manufacturing and as our Vice President of Research from December 2006 to May 2012. He has worked in various advanced ceramic product development, quality engineering and manufacturing roles at Applied Materials, Inc., Norton Advanced Ceramics, a division of Saint-Gobain Industrial Ceramics Corporation, Norton/TRW Ceramics and Ceramatec, Inc., a small producer of ionic-conducting and structural ceramic components located in Salt Lake City, Utah. Mr. McEntire holds a B.S. degree in Materials Science and Engineering and an M.B.A. from the University of Utah.

Dana Lyons

Mr. Dana Lyons serves as Vice President - Sales and Marketing of the Company. Mr. Lyons will lead the effort to increase the adoption of silicon nitride implants in the spinal fusion market and deliver revenue growth. He brings over 27 years of sales and sales management experience in the medical device industry. Mr. Lyons joins Amedica after holding multiple sales management and sales leadership positions with Stryker Orthopaedics, Zimmer Spine, and Zimmer Biomet Spine. During his tenure as Sales Vice President with Zimmer Spine and in conjunction with the Zimmer Spine executive leadership team, Zimmer Spine delivered 5 consecutive quarters of growth during 2014-2015. After the Zimmer and Biomet merger in June of 2015, Mr. Lyons successfully integrated the sales organizations of both Zimmer Spine and Biomet Spine in the Central Region of the United States.

Eric Stookey

Mr. Eric A. Stookey has been appointed as Independent Director of Amedica Corporation., effective October 6, 2014. Mr. Stookey has served as Chief Operating Officer of Osteoremedies, LLC since March of 2015. From October 2011 until August 2014, Mr. Stookey served as the President of the Extremities-Biologics division at Wright Medical Group Inc. Mr. Stookey also served in various other marketing and sales positions at Wright Medical Group Inc. since 1995, including as the Senior Vice President and Chief Commercial Officer from January 2010 to November 2011, as the Vice President North American Sales from 2007 to January 2010, as the Vice President US Sales from 2005 to 2007, as the Senior Director of Sales, Central Region, from 2003 to 2005 and as the Director of Marketing for Large Joint Reconstruction Products from 2001 to 2003. Mr. Stookey earned his M.B.A. from Christian Brothers University and his B.S. in Business from the Indiana University School of Business. We believe that Mr. Stookey’s industry and executive leadership experience qualifies him to serve on our board of directors.

David Truetzel

Mr. David W. Truetzel, CPA., is Independent Director at Amedica Corporation. Mr. Truetzel has been the general partner of Augury Capital Partners, a private equity fund that invests in life sciences and information technology companies, which he co-founded in 2006. Mr. Truetzel is a director of Enterprise Bank, Inc., Verifi, Inc., a provider of electronic payment solutions, Clearent, LLC, a credit card processing provider, and Paranet, LLC, an IT services provider. Mr. Truetzel holds a B.S. in Business Administration from Saint Louis University and an M.B.A. from The Wharton School. We believe that Mr. Truetzel’s financial and managerial expertise qualify him to serve on our board of directors.

Jeffrey White

Mr. Jeffrey S. White is Independent Director of Amedica Corporation. Since July 2014 Mr. White has served as President, Liventa Bioscience, a company which offers specialty amniotic tissue allografts for use in surgical and wound care applications; he has also served on the Board of Liventa Bioscience since January 2014. Since January 2013, Mr. White has served as Principal at Medtech Advisory Group LLC, a firm he founded that advises early and mid-stage medical technology firms. Mr. White is currently a director of Residency Select LLC, a company which offers psychometric assessment, training and compliance products to medical and surgical residency programs. From May 2006 to December 2012 he served as Global Director of Business Development for Synthes Inc., a global orthopedic firm that was acquired by Johnson and Johnson in 2012. Mr. White has served as Chief Executive Officer and co-founder of several start-up surgical device firms and has previously held executive level positions at Richard-Allan Medical Industries Inc., a medical device manufacturer, which was acquired by Urohealth Systems Inc. and United States Surgical Corporation, unit of Covidien plc. Mr. White holds a B.S. in Biology from Union College in Schenectady NY. We believe that Mr. White’s experience as an executive and founder of medical device companies qualifies him to serve on our board of directors.

Mike Houston

Basic Compensation

Name Fiscal Year Total

B. Sonny Bal

156,693

Bryan McEntire

326,225

Dana Lyons

--

Eric Stookey

--

David Truetzel

--

Jeffrey White

--

Mike Houston

--
As Of  30 Dec 2014

Options Compensation